| Date | Title | Description | Source |
| 08.03.2024 | TG Therapeutics Announces Schedule of Data Presentations for... | - | globenewsw... |
| 04.01.2022 | TG Therapeutics Expands Term Loan Facility With Hercules Cap... | NEW YORK, Jan. 04, 2022 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced th... | marketscre... |
| 04.01.2022 | TG Therapeutics Expands Term Loan Facility with Hercules Cap... | TG Therapeutics, Inc. announced that its existing term loan facility agreement with Hercules Capital... | marketscre... |
| 04.01.2022 | TG Therapeutics Expands Term Loan Facility With Hercules Cap... | NEW YORK, Jan. 04, 2022 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced th... | globenewsw... |
| 30.11.2021 | FDA raises concerns over TG Therapeutics' survival da... | TG Therapeutics took a hit Tuesday morning after announcing the FDA will convene an adcomm... | endpts.com... |
| 04.11.2021 | TG Therapeutics Provides Business Update and Reports Third Q... | TG Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results
Conference... | marketscre... |
| 04.11.2021 | TG Therapeutics Provides Business Update and Reports Third Q... | NEW YORK, Nov. 04, 2021 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its... | marketscre... |
| 14.10.2021 | TG Therapeutics : Announces Data for Ublituximab in Multiple... | New ULTIMATE I & II data presented at ECTRIMS shows ublituximab treatment is associated with sig... | marketscre... |
| 29.09.2021 | TG Therapeutics : Announces Data Presentations from the ULTI... | The ULTIMATE I & II Phase 3 trials both have met their primary endpoint with ublituximab treatme... | marketscre... |
| 20.09.2021 | TG Therapeutics : Announces Combination Data Presentations a... | NEW YORK, Sept. 20, 2021 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced d... | marketscre... |
| 02.08.2021 | TG Therapeutics : Provides Business Update and Reports Secon... | TG Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results
Conferenc... | marketscre... |
| 02.08.2021 | TG Therapeutics : Provides Business Update and Reports Secon... | NEW YORK, Aug. 02, 2021 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its... | marketscre... |
| 14.06.2021 | TG THERAPEUTICS, INC.
TG Therapeutics : Announces Data from... | NEW YORK - TG Therapeutics, Inc. (NASDAQ: TGTX), announced data from TG-1701, the Company's investig... | marketscre... |
| 07.06.2021 | TG THERAPEUTICS, INC.
TG Therapeutics : Announces Data from... | NEW YORK - TG Therapeutics, Inc. (NASDAQ: TGTX), announced data from TG-1701, the Company's investig... | marketscre... |
| 04.06.2021 | TG THERAPEUTICS, INC.
TG Therapeutics : Announces Data from... | 100% ORR in CLL patients treated with 300 mg QD of TG-1701 monotherapy (n=19)
Triple combination of ... | marketscre... |
| 16.04.2021 | TG Therapeutics prepares to approach regulators with... | Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in yo... | endpts.com... |
| 16.04.2021 | Covid-19 roundup: Biden invests $1.7B to address Covid var... | The Biden administration said Friday that it’ll pump $1.7 billion into various programs to... | endpts.com... |
| 16.04.2021 | In one of their first ever acquisitions, Relay bets $85M... | Although they’ve never been short for cash, Relay Therapeutics hasn’t been one for acquisit... | endpts.com... |
| 16.04.2021 | Looking to cement its lead in packed MS market, Roche's O... | Among a positively jam-packed multiple sclerosis market, Roche’s Ocrevus has managed to st... | endpts.com... |
| 16.04.2021 | Covid-19 roundup: Biden invests $1.7B to address Covid var... | The CDC’s Advisory Committee on Immunization Practices punted earlier this week on deciding whether ... | endpts.com... |
| 16.04.2021 | Novavax CFO Greg Covino makes a quick exit as leadershi... | Greg Covino
→ If it seems like Covid-19 vaccine bridesmaid Novavax is shuttling staffers in and... | endpts.com... |
| 16.04.2021 | TG Therapeutics prepares to approach regulators with... | Samumed made quite the entrance back in 2016, when it launched with some anti-aging programs and a w... | endpts.com... |
| 16.04.2021 | TG THERAPEUTICS, INC.
TG Therapeutics Announces Positive Re... | Ublituximab demonstrated superiority versus teriflunomide in reducing annualized relapse rates and M... | marketscre... |
| 16.04.2021 | TG Therapeutics prepares to approach regulators with... | Gearing up for a battle with pharma giants, TG Therapeutics says it’s nearly ready to appro... | endpts.com... |
| 15.04.2021 | Abzena picks North Carolina as the home for its 6th manu... | While Boston and San Francisco are the unquestioned leading biotech hubs in the US, drugmaker... | endpts.com... |
| 10.12.2020 | Angling for a spot among the giants, TG Therapeutics to... | While the pharma giants duke it out in multiple sclerosis, a biotech is taking a crack at the... | endpts.com... |
| 10.11.2020 | TG THERAPEUTICS, INC.
TG Therapeutics Provides Business Upd... | NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its... | marketscre... |
| 10.11.2020 | TG THERAPEUTICS, INC.
TG Therapeutics : Provides Business U... | NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its... | marketscre... |
| 11.10.2020 | TG Therapeutics : Provides Business Update and Reports Third... | NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its... | marketscre... |
| 22.01.2019 | TG Therapeutics' shares jump as umbralisib wins FDA's... | About a month after the publication of encouraging results from an early-stage study evalu... | endpts.com... |
| 04.07.2018 | Novimmune to receive up to $185M milestone payments | | startuptic... |
| 06.03.2017 | TG Therapeutics shares rocket up on successful PhIII ... | Michael S. Weiss
Shares of TG Therapeutics $TGTX rocketed up 64% this morning after the New Y... | endpts.com... |
| 06.05.2013 | Former Keryx Exec’s Mission: Turn TG Into the Next Pharmacyc... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Seven years running a publicly-trad... | xconomy.co... |
| - | Here are the 15 highest-paid CEOs in biopharma, bringing in ... | This story is available exclusively to Insider subscribers. Become an Insider and start reading now.... | businessin... |
| - | Stocks making the biggest moves midday: Netflix, Cal-Maine F... | Check out the companies making headlines in midday trading.
Netflix — The streaming giant gained 5.1... | cnbc.com/2... |
